[18F]FDG PET/CT在多发性骨髓瘤中的影像组学与人工智能研究全景
本文综述了[18F]FDG PET/CT在多发性骨髓瘤中的应用,指出因骨髓浸润模式异质复杂,PET/CT判读困难且观察者间可重复性受限,目前尚无标准化判读或客观量化方法。影像组学结合机器学习与深度学习在[18F]FDG PET/CT多发性骨髓瘤中的初步研究已取得令人鼓舞的结果,可能有助于判读的优化与标准化。
要点
- [18F]FDG PET/CT是多发性骨髓瘤疗效评估的合适方法,但骨髓浸润模式异质复杂使判读具有挑战性。
- 目前尚无可被视为标准化判读或客观量化PET/CT的方法,需要先进诊断量化手段支持疾病管理。
- 影像组学与人工智能方法在多发性骨髓瘤[18F]FDG PET/CT中的初步研究结果令人鼓舞。
核心结论
- 影像组学与人工智能方法在多发性骨髓瘤[18F]FDG PET/CT领域的初步文献已取得令人鼓舞的结果,可能成为优化和标准化判读的可靠工具。
研究设计与样本
- 本文为综述,汇总影像组学与人工智能方法在多发性骨髓瘤[18F]FDG PET/CT中应用的主要研究结果。
主要发现
- [18F]FDG PET/CT在多发性骨髓瘤中性能高,被认为是评估治疗反应的合适方法。
- 多发性骨髓瘤骨髓浸润模式异质且有时复杂,使PET/CT判读具有挑战性,影响观察者间可重复性并限制该方法的诊断和预后能力。
- 尽管已开发许多方法处理标准化问题,目前尚无可被视为标准化判读或客观量化PET/CT的方法。
- 影像组学已出现为高通量挖掘图像衍生特征用于临床决策的创新方法,在肿瘤学中可能特别有帮助。
- 机器学习和深度学习与影像组学过程密切相关,已越来越多地应用于自动化图像分析,为肿瘤学中CT、PET/CT和MRI等影像模态的标准化评估提供新可能。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
[18F]FDG PET/CT is a powerful imaging modality of high performance in multiple myeloma (MM) and is considered the appropriate method for assessing treatment response in this disease. On the other hand, due to the heterogeneous and sometimes complex patterns of bone marrow infiltration in MM, the interpretation of PET/CT can be particularly challenging, hampering interobserver reproducibility and limiting the diagnostic and prognostic ability of the modality. Although many approaches have been developed to address the issue of standardization, none can yet be considered a standard method for interpretation or objective quantification of PET/CT. Therefore, advanced diagnostic quantification approaches are needed to support and potentially guide the management of MM. In recent years, radiomics has emerged as an innovative method for high-throughput mining of image-derived features for clinical decision making, which may be particularly helpful in oncology. In addition, machine learning and deep learning, both subfields of artificial intelligence (AI) closely related to the radiomics process, have been increasingly applied to automated image analysis, offering new possibilities for a standardized evaluation of imaging modalities such as CT, PET/CT and MRI in oncology. In line with this, the initial but steadily growing literature on the application of radiomics and AI-based methods in the field of [18F]FDG PET/CT in MM has already yielded encouraging results, offering a potentially reliable tool towards optimization and standardization of interpretation in this disease. The main results of these studies are presented in this review.
引用
- Sachpekidis C, Goldschmidt H, Edenbrandt L, et al. Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma. Semin Nucl Med. 2024. PMID: 39674756. doi:10.1053/j.semnuclmed.2024.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。